| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.55 | 0.002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.003 |